Monday 17 May 2021
Home      All news      Contact us      RSS      India
business-standard. - 26 days ago

Covaxin shows 78% efficacy in Phase 3 interim analysis, says Bharat Biotech

The Phase 3 study enrolled 25,800 participants between 18-98 years of age, including 10% over the age of 60, says the Hyderabad-based firm


Latest News
Hashtags:   

Covaxin

 | 

shows

 | 

efficacy

 | 

Phase

 | 

interim

 | 

analysis

 | 

Bharat

 | 

Biotech

 | 

Sources